JPWO2020109439A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020109439A5
JPWO2020109439A5 JP2021530284A JP2021530284A JPWO2020109439A5 JP WO2020109439 A5 JPWO2020109439 A5 JP WO2020109439A5 JP 2021530284 A JP2021530284 A JP 2021530284A JP 2021530284 A JP2021530284 A JP 2021530284A JP WO2020109439 A5 JPWO2020109439 A5 JP WO2020109439A5
Authority
JP
Japan
Prior art keywords
mypop
seq
cancer
acid sequence
myb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021530284A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513152A (ja
JP7642538B2 (ja
JP2022513152A5 (https=
Publication date
Priority claimed from US16/206,526 external-priority patent/US20200174016A1/en
Application filed filed Critical
Publication of JP2022513152A publication Critical patent/JP2022513152A/ja
Publication of JPWO2020109439A5 publication Critical patent/JPWO2020109439A5/ja
Publication of JP2022513152A5 publication Critical patent/JP2022513152A5/ja
Application granted granted Critical
Publication of JP7642538B2 publication Critical patent/JP7642538B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021530284A 2018-11-30 2019-11-28 腫瘍療法の診断マーカー及び治療標的としてのＭｙｂ関連転写因子（ＭＹＰＯＰ） Active JP7642538B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/206,526 US20200174016A1 (en) 2018-11-30 2018-11-30 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy
US16/206,526 2018-11-30
PCT/EP2019/082845 WO2020109439A1 (en) 2018-11-30 2019-11-28 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy

Publications (4)

Publication Number Publication Date
JP2022513152A JP2022513152A (ja) 2022-02-07
JPWO2020109439A5 true JPWO2020109439A5 (https=) 2023-01-11
JP2022513152A5 JP2022513152A5 (https=) 2023-01-11
JP7642538B2 JP7642538B2 (ja) 2025-03-10

Family

ID=68848224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021530284A Active JP7642538B2 (ja) 2018-11-30 2019-11-28 腫瘍療法の診断マーカー及び治療標的としてのＭｙｂ関連転写因子（ＭＹＰＯＰ）

Country Status (5)

Country Link
US (2) US20200174016A1 (https=)
EP (1) EP3887550A1 (https=)
JP (1) JP7642538B2 (https=)
CA (1) CA3121047A1 (https=)
WO (1) WO2020109439A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2721179A4 (en) * 2011-06-16 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L BIOMARKER COMPOSITIONS AND METHOD THEREFOR

Similar Documents

Publication Publication Date Title
CN109790583B (zh) 对肺腺癌亚型分型的方法
JPWO2014007369A1 (ja) Ｆｇｆｒ２融合遺伝子
US20090203072A1 (en) Detection for HPV-Induced invasive cancers and their precursor lesions with invasive potential
WO2014017491A1 (ja) Ｃｅｐ５５遺伝子とｒｅｔ遺伝子との融合遺伝子
CN101246169B (zh) 口腔鳞癌诊断试剂、试剂盒及防治药物
RU2013113314A (ru) Способы выявления антител против не4 и способы диагностики и/или прогнозирования состояний, ассоциированных с экспрессирующими не4 клетками
JP2011254830A (ja) 結腸癌に関するポリヌクレオチド
US20030065156A1 (en) Novel human genes and gene expression products I
US20160267244A1 (en) Methods of predicting cancer lethality using replikin counts
CN107164554B (zh) Asprv1作为生物标志物在喉鳞癌诊疗中的应用
WO2009116860A1 (en) Markers providing prognosis of metastasis among cancer patients
EP2320932B1 (en) Methods of predicting cancer lethality using replikin counts
CN106811532B (zh) Acta1作为舌鳞癌诊治标志物的用途
CN113293208B (zh) 与肺癌增殖和转移相关的分子标志物及其应用
CN113528667B (zh) 一种骨巨细胞瘤的诊断方法
JPWO2020109439A5 (https=)
CN111139299B (zh) Josd2蛋白在制备治疗恶性肿瘤药物中的应用
CN111424092B (zh) 一种检测基因及其应用
JPWO2002083899A1 (ja) 癌関連遺伝子
CN118547073B (zh) 口腔癌诊断标志物SLC37A4 -Exon7剪切异构体及应用
CN112661826A (zh) 小肽ERpeptide及其在急性髓系白血病中的应用
CN111979328A (zh) 一种预测肝癌肺转移的生物标志物及其应用
WO2020174478A1 (en) Diagnosis and treatment of medulloblastoma
EP1151094A1 (en) Cervical cancer treatment
CN121059800A (zh) Dhcr24与宫颈癌诊断、治疗、预后相关的用途